Meta facebook tracking pixel

Upcoming Workshops

For All Cancers

  1. Register
  2. Register
  3. Register
  4. Register

For Breast Cancer

  1. Register

For Cervical Cancer

  1. Register

For Lymphoma

  1. Register

Past workshops

For All Cancers

    1. Participating in Decisions about Your CarePart I of Life with Cancer
    2. Coping with Cancer
    3. Veterans and Cancer: Unique Challenges
    4. Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    5. Current Perspectives on the Future of Cancer Research
    6. Managing Eye and Vision Changes Related to Cancer Treatments
    7. Understanding the Different Names for Biomarker Testing and Their Role in Selecting the Best Treatment for YouPart II of What You Need to Know About Biomarkers in the Treatment of Cancer Makes All the Difference in the World
    8. Understanding the Important Role that Biomarker Testing Plays in Informing the Treatment of CancerPart I of What You Need to Know About Biomarkers in the Treatment of Cancer Makes All the Difference in the World
    9. Clinical Trials: How They Transform the Treatment of Cancer
    10. Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects
    11. Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects

For Acute Lymphoblastic Leukemia

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Acute Myeloid Leukemia

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma

For Bladder Cancer

    1. Bladder Cancer: Treatment UpdatesPart I of Living with Bladder Cancer

For Brain Cancer

    1. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart I of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future

For Breast Cancer

    1. Cáncer de Mama en la Comunidad Hispana (Breast Cancer in the Hispanic Community)
    2. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 48th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 48th Annual San Antonio Breast Cancer Symposium
    3. Updates from the 48th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
    4. Updates from the 48th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer – Updates from the 48th Annual San Antonio Breast Cancer Symposium
    5. Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Triple Negative Breast Cancer
    6. Triple Negative Breast Cancer and African American Women
    7. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
    8. Updates from the 2025 American Society of Clinical Oncology (ASCO) Annual Conference on Triple Negative Breast Cancer
    9. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart I of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
    10. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality-of-Life
    11. Metastatic Breast Cancer: Treatment Updates
    12. Understanding HER2 Low Breast Cancer
    13. Breast Cancer in Younger Women: New Treatment Options
    14. Breast Cancer in Men: Diagnosis, Treatment and Survivorship
    15. The Benefits of Clinical Trials for Triple Negative Breast Cancer

For Cervical Cancer

    1. Advances in the Treatment of Cervical Cancer

For Chronic Lymphocytic Leukemia

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Living with Chronic Lymphocytic Leukemia
    3. Updates on CAR T-cell Therapies
    4. Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia

For Chronic Myelogenous Leukemia

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Colorectal Cancer

    1. What’s New in Precision Medicine
    2. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart II of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
    3. Advances in the Treatment of Colorectal Cancer

For Cutaneous T-Cell Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Diffuse Large B-Cell Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    3. Updates on CAR T-cell Therapies

For Endometrial Cancer

    1. Progress in the Treatment of Endometrial Cancer

For Follicular Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Update on Follicular Lymphoma
    3. Updates on CAR T-cell Therapies

For Gastric Cancer

    1. Advances in the Treatment of Gastric Cancer

For Gastrointestinal Stromal Tumors

    1. Advances in the Treatment of Gastric Cancer

For Head and Neck Cancer

    1. Treatment Update on Oral, Head and Neck Cancer
    2. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart I of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
    3. Treatment Update in Oral and Head and Neck Cancer

For Hodgkin Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Leukemia

    1. What’s New in Precision Medicine
    2. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    3. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart II of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
    4. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Living with Chronic Lymphocytic Leukemia
    5. Updates on CAR T-cell Therapies
    6. Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia

For Liver Cancer

    1. Liver Cancer: Treatment Update
    2. Liver Cancer: Treatment Update

For Lung Cancer

    1. What’s New in Precision Medicine
    2. Non-Small Cell Lung Cancer: For Caregivers - Practical Tips for CopingPart III of Living with Non-Small Cell Lung Cancer
    3. Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
    4. Living with Small Cell Lung Cancer
    5. Diverse Populations Living with Non-Small Cell Lung Cancer

For Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart II of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
    3. Update on Follicular Lymphoma
    4. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
    5. Updates on CAR T-cell Therapies

For Mantle Cell Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Marginal Zone Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Melanoma

    1. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart II of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
    2. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma

For Metastatic Breast Cancer

    1. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality-of-Life
    2. Metastatic Breast Cancer: Treatment Updates
    3. Breast Cancer in Younger Women: New Treatment Options

For Multiple Myeloma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
    3. Updates on CAR T-cell Therapies

For Myelodysplastic Syndromes

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    3. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    4. Updates on CAR T-cell Therapies

For Myelofibrosis

    1. Myelofibrosis: Treatment Progress
    2. Updates on CAR T-cell Therapies

For Myeloproliferative Neoplasms

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies
    3. Progress in the Treatment of Myeloproliferative Neoplasms (MPNs)Part I of Living with Myeloproliferative Neoplasms

For Non-Hodgkin Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Ovarian Cancer

    1. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart I of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
    2. Update on the Treatment of Ovarian Cancer

For Pancreatic Cancer

    1. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart II of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future

For Peripheral T-Cell Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Polycythemia Vera

    1. Updates on CAR T-cell Therapies

For Prostate Cancer

    1. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart I of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future

For Rare Cancers

    1. Update on Epithelioid Sarcoma

For Renal Cell Cancer

    1. Advances in the Treatment of Renal Cell Cancer

For Sarcoma

    1. Updates on the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
    2. Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better FuturePart I of Highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting — Driving Knowledge to Action: Building a Better Future
    3. Update on Epithelioid Sarcoma

For Skin Cancer

    1. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma

For Small Lymphocytic Lymphoma

    1. Updates from the 2025 American Society of Hematology (ASH) Annual Meeting
    2. Updates on CAR T-cell Therapies

For Squamous Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma

For Stomach Cancer

    1. Advances in the Treatment of Gastric Cancer

For Thyroid Cancer

For Triple Negative Breast Cancer

    1. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    2. Updates from the 48th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
    3. Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Triple Negative Breast Cancer
    4. Triple Negative Breast Cancer and African American Women
    5. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
    6. Updates from the 2025 American Society of Clinical Oncology (ASCO) Annual Conference on Triple Negative Breast Cancer
    7. Breast Cancer in Younger Women: New Treatment Options
    8. The Benefits of Clinical Trials for Triple Negative Breast Cancer

For Waldenstrom’s Macroglobulinemia

    1. Updates on CAR T-cell Therapies
Back to Top